Literature DB >> 12675159

Cooperative interactions at M2 muscarinic acetylcholine receptors: structure/activity relationships in stepwise shortened bispyridinium- and bis(ammonio)alkane-type allosteric modulators.

Ralf Gilsbach1, Maren Grossmüller, Vildan Alptüzün, Ercin Erciyas, Christian Tränkle, Ulrike Holzgrabe, Klaus Mohr.   

Abstract

Muscarinic M2-receptors allow for divergent modes of allosteric action, depending on the structure of the allosteric modulator. Phthalimido-substituted bis(ammonio)alkane-type modulators belong to the common mode allosteric agents, whereas a physicochemically closely related bispyridinium-oxime with dichlorobenzyl-substituents at both ends is an atypical agent. Here, we compared the actions of stepwise shortened compounds composed of the phthalimido moiety and middle chains of either the bispyridinium- or the bis(ammonio)alkane-type. Allosteric interactions were measured in pig M2 receptors with the orthosteric probe [3H]N-methylscopolamine ([3H]NMS) to label the acetylcholine binding site of the receptors. Dissociation and equilibrium binding experiments revealed parallel structure/activity-relationships in both series of compounds with regard to the cooperativity of interaction with [3H]NMS and to the underlying binding affinities in radioligand-occupied and free receptors. In conclusion, the findings are in line with the hypothesis that the phthalimido-moiety, but not the middle chain, is pivotal for the topology of interaction with the M2-receptor protein.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12675159     DOI: 10.1023/a:1022858414900

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  33 in total

1.  Positive cooperativity of acetylcholine and other agonists with allosteric ligands on muscarinic acetylcholine receptors.

Authors:  J Jakubík; L Bacáková; E E El-Fakahany; S Tucek
Journal:  Mol Pharmacol       Date:  1997-07       Impact factor: 4.436

2.  Allosteric site on muscarinic acetylcholine receptors: a single amino acid in transmembrane region 7 is critical to the subtype selectivities of caracurine V derivatives and alkane-bisammonium ligands.

Authors:  Stefan Buller; Darius Paul Zlotos; Klaus Mohr; John Ellis
Journal:  Mol Pharmacol       Date:  2002-01       Impact factor: 4.436

3.  M2 receptor binding of the selective antagonist AF-DX 384: possible involvement of the common allosteric site.

Authors:  C Tränkle; I Andresen; G Lambrecht; K Mohr
Journal:  Mol Pharmacol       Date:  1998-02       Impact factor: 4.436

4.  Site-directed mutagenesis reveals two epitopes involved in the subtype selectivity of the allosteric interactions of gallamine at muscarinic acetylcholine receptors.

Authors:  A L Gnagey; M Seidenberg; J Ellis
Journal:  Mol Pharmacol       Date:  1999-12       Impact factor: 4.436

5.  Subtype-selective positive cooperative interactions between brucine analogs and acetylcholine at muscarinic receptors: functional studies.

Authors:  N J Birdsall; T Farries; P Gharagozloo; S Kobayashi; S Lazareno; M Sugimoto
Journal:  Mol Pharmacol       Date:  1999-04       Impact factor: 4.436

6.  Allosteric modulation of muscarinic receptor signaling: alcuronium-induced conversion of pilocarpine from an agonist into an antagonist.

Authors:  Katrin Zahn; Niels Eckstein; Christian Tränkle; Wolfgang Sadée; Klaus Mohr
Journal:  J Pharmacol Exp Ther       Date:  2002-05       Impact factor: 4.030

7.  Allosteric interactions of staurosporine and other indolocarbazoles with N-[methyl-(3)H]scopolamine and acetylcholine at muscarinic receptor subtypes: identification of a second allosteric site.

Authors:  S Lazareno; A Popham; N J Birdsall
Journal:  Mol Pharmacol       Date:  2000-07       Impact factor: 4.436

8.  The effects of brucine and alcuronium on the inhibition of [3H]acetylcholine release from rat striatum by muscarinic receptor agonists.

Authors:  V Dolezal; S Tucek
Journal:  Br J Pharmacol       Date:  1998-07       Impact factor: 8.739

9.  Identification of a [3H]Ligand for the common allosteric site of muscarinic acetylcholine M2 receptors.

Authors:  C Tränkle; E Mies-Klomfass; M H Cid; U Holzgrabe; K Mohr
Journal:  Mol Pharmacol       Date:  1998-07       Impact factor: 4.436

10.  Positive allosteric interactions on cardiac muscarinic receptors: effects of chemical modifications of disulphide and carboxyl groups.

Authors:  J Jakubík; S Tucek
Journal:  Eur J Pharmacol       Date:  1995-04-28       Impact factor: 4.432

View more
  3 in total

1.  DFT calculation of four new potential agents muscarinic of bispyridinium type: structure, synthesis, biological activity, hydration, and relations with the potents W84 and DUO-3O.

Authors:  M Alcolea Palafox; P Posada-Moreno; A L Villarino-Marín; C Martinez-Rincon; I Ortuño-Soriano; I Zaragoza-García
Journal:  J Comput Aided Mol Des       Date:  2010-12-22       Impact factor: 3.686

2.  Allosteric site in M2 acetylcholine receptors: evidence for a major conformational change upon binding of an orthosteric agonist instead of an antagonist.

Authors:  Maren Grossmüller; Johannes Antony; Christian Tränkle; Ulrike Holzgrabe; Klaus Mohr
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2005-12-16       Impact factor: 3.000

3.  Allosteric modulation of muscarinic acetylcholine receptors.

Authors:  Karen J Gregory; Patrick M Sexton; Arthur Christopoulos
Journal:  Curr Neuropharmacol       Date:  2007-09       Impact factor: 7.363

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.